Butyric Acid Derivatives in Myeloid Malignancies - Steven Gore

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: Research Project (R01)
Project #: 5R01CA067803-02
Application #: 2111582
Study Section: Special Emphasis Panel (SRC (14))

Project Start: 1995-08-01
Project End: 1999-07-31
Budget Start: 1996-08-01
Budget End: 1997-07-31
Support Year: 2
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: Johns Hopkins University
Department: Internal Medicine/Medicine
Type: Schools of Medicine
DUNS #: 045911138

City: Baltimore
State: MD
Country: United States
Zip Code: 21218

Related projects


NIH 1999 R01 CA	Butyric Acid Derivatives in Myeloid Malignancies Gore, Steven D. / Johns Hopkins University
NIH 1998 R01 CA	Butyric Acid Derivatives in Myeloid Malignancies Gore, Steven D. / Johns Hopkins University
NIH 1997 R01 CA	Butyric Acid Derivatives in Myeloid Malignancies Gore, Steven D. / Johns Hopkins University
NIH 1996 R01 CA	Butyric Acid Derivatives in Myeloid Malignancies Gore, Steven D. / Johns Hopkins University
NIH 1995 R01 CA	Butyric Acid Derivatives in Myeloid Malignancies Gore, Steven D. / Johns Hopkins University

Publications

Gore, Steven D; Weng, Li-Jun; Figg, William D et al. (2002) Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. Clin Cancer Res 8:963-70

Gore, S D; Weng, L J; Zhai, S et al. (2001) Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. Clin Cancer Res 7:2330-9

Comments

Be the first to comment on Steven Gore's grant